The same iron oxide nanoparticles developed by Zhang et al. for AD were also shown to reduce α-synuclein accumulation and the activation of caspase-3 in PD, which is a marker for cell death in the PD cell model [154]. This evidence concerns the gene CASP3 and Parkinson disease.